Pediatrix Medical Group, Inc. (NYSE:MD) Receives Consensus Rating of “Moderate Buy” from Analysts

Pediatrix Medical Group, Inc. (NYSE:MD) has received an average recommendation of “Moderate Buy” from the eight research firms that are covering the stock, Marketbeat.com reports. Five equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $16.7857.

MD has been the subject of several recent analyst reports. Wall Street Zen cut shares of Pediatrix Medical Group from a “strong-buy” rating to a “buy” rating in a research report on Saturday, September 13th. Zacks Research raised shares of Pediatrix Medical Group to a “strong-buy” rating in a research report on Monday, August 11th. UBS Group increased their target price on shares of Pediatrix Medical Group from $16.00 to $16.50 and gave the stock a “neutral” rating in a report on Thursday, August 14th. Finally, Leerink Partners increased their target price on shares of Pediatrix Medical Group from $14.50 to $17.00 and gave the stock a “market perform” rating in a report on Friday, September 5th.

Pediatrix Medical Group Trading Up 0.5%

MD opened at $17.09 on Friday. Pediatrix Medical Group has a twelve month low of $11.59 and a twelve month high of $17.67. The company has a 50-day simple moving average of $15.72 and a 200 day simple moving average of $14.38. The company has a quick ratio of 1.80, a current ratio of 1.80 and a debt-to-equity ratio of 0.70. The stock has a market capitalization of $1.49 billion, a price-to-earnings ratio of 13.25 and a beta of 1.26.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.53 earnings per share for the quarter, topping the consensus estimate of $0.42 by $0.11. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The business had revenue of $468.84 million during the quarter, compared to analysts’ expectations of $464.37 million. During the same quarter in the prior year, the business posted $0.34 earnings per share. Pediatrix Medical Group’s revenue was down 7.1% compared to the same quarter last year. Analysts predict that Pediatrix Medical Group will post 1.38 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Squarepoint Ops LLC lifted its holdings in shares of Pediatrix Medical Group by 234.6% in the second quarter. Squarepoint Ops LLC now owns 81,142 shares of the company’s stock worth $1,164,000 after acquiring an additional 56,889 shares during the last quarter. Nomura Holdings Inc. lifted its holdings in shares of Pediatrix Medical Group by 121.4% in the second quarter. Nomura Holdings Inc. now owns 576,730 shares of the company’s stock worth $8,276,000 after acquiring an additional 316,274 shares during the last quarter. Caxton Associates LLP bought a new position in shares of Pediatrix Medical Group in the second quarter worth about $236,000. Public Sector Pension Investment Board lifted its holdings in shares of Pediatrix Medical Group by 7.1% in the second quarter. Public Sector Pension Investment Board now owns 287,060 shares of the company’s stock worth $4,119,000 after acquiring an additional 18,984 shares during the last quarter. Finally, CANADA LIFE ASSURANCE Co lifted its holdings in shares of Pediatrix Medical Group by 5.5% in the second quarter. CANADA LIFE ASSURANCE Co now owns 72,638 shares of the company’s stock worth $1,043,000 after acquiring an additional 3,767 shares during the last quarter. Institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.